$IDEV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Endo Pharmaceuticals Solutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Endo Pharmaceuticals Solutions Inc.. Get notifications about new insider transactions in Endo Pharmaceuticals Solutions Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 438,462 | 0 | 70,856,245 | 70.4 M to 70.9 M (+0.62 %) |
Mar 20 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 197,521 | 0 | 70,417,783 | 70.2 M to 70.4 M (+0.28 %) |
Mar 17 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 287,810 | 0 | 70,220,262 | 69.9 M to 70.2 M (+0.41 %) |
Mar 17 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 3,300,098 | 0 | 69,932,452 | 66.6 M to 69.9 M (+4.95 %) |
Mar 17 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 462,145 | 0 | 66,632,354 | 66.2 M to 66.6 M (+0.70 %) |
Mar 12 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 359,178 | 0 | 66,170,209 | 65.8 M to 66.2 M (+0.55 %) |
Mar 12 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 188,309 | 0 | 65,811,031 | 65.6 M to 65.8 M (+0.29 %) |
Mar 12 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 111,250 | 0 | 65,622,722 | 65.5 M to 65.6 M (+0.17 %) |
Mar 09 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 520,180 | 0 | 65,511,472 | 65 M to 65.5 M (+0.80 %) |
Mar 09 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 206,615 | 0 | 64,991,292 | 64.8 M to 65 M (+0.32 %) |
Mar 09 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 1,022,729 | 0 | 64,784,677 | 63.8 M to 64.8 M (+1.60 %) |
Mar 09 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | U | 4.50 | 2,221,248 | 9,995,616 | 7,891,067 | 10.1 M to 7.9 M (-21.97 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 3,500 | 0 | 59,607,678 | 59.6 M to 59.6 M (+0.01 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 160,747 | 0 | 59,604,178 | 59.4 M to 59.6 M (+0.27 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 226,812 | 0 | 59,443,431 | 59.2 M to 59.4 M (+0.38 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 1,097,646 | 0 | 59,216,619 | 58.1 M to 59.2 M (+1.89 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 190,162 | 0 | 58,119,973 | 57.9 M to 58.1 M (+0.33 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 10,660 | 0 | 57,929,811 | 57.9 M to 57.9 M (+0.02 %) |
Mar 04 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 2,911,002 | 0 | 57,919,151 | 55 M to 57.9 M (+5.29 %) |
Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.49 | 25,000 | 137,125 | 10,112,315 | 10.1 M to 10.1 M (+0.25 %) |
Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.49 | 225,000 | 1,234,125 | 10,087,315 | 9.9 M to 10.1 M (+2.28 %) |
Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.55 | 7,500 | 41,634 | 9,862,315 | 9.9 M to 9.9 M (+0.08 %) |
Feb 26 2009 | IDEV | Endo Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 5.55 | 675,000 | 3,747,060 | 9,787,315 | 9.1 M to 9.8 M (+7.41 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Sell | U | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | FERRARA ANDREW J | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | FERRARA ANDREW J | Director | Sell | U | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | FERRARA ANDREW J | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Sell | U | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Sell | U | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 0 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Sell | U | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Sell | U | 0.00 | 27,000 | 0 | 0 | 27 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | CEO | Option Exercise | M | 0.00 | 279,898 | 0 | 52,412 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | CEO | Sell | U | 0.00 | 279,898 | 0 | 0 | 279.9 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | CEO | Buy | M | 0.00 | 279,898 | 0 | 279,898 | 0 to 279.9 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | CEO | Sell | U | 0.00 | 467,091 | 0 | 0 | 467.1 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 0.00 | 100,443 | 0 | 18,174 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | U | 0.00 | 100,443 | 0 | 0 | 100.4 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Buy | M | 0.00 | 100,443 | 0 | 100,443 | 0 to 100.4 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | U | 0.00 | 130,601 | 0 | 0 | 130.6 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 100,443 | 0 | 18,174 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | U | 0.00 | 100,443 | 0 | 0 | 100.4 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Buy | M | 0.00 | 100,443 | 0 | 100,443 | 0 to 100.4 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | U | 0.00 | 83,528 | 0 | 0 | 83.5 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | M | 0.00 | 100,443 | 0 | 18,174 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Sell | U | 0.00 | 100,443 | 0 | 0 | 100.4 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Buy | M | 0.00 | 100,443 | 0 | 100,443 | 0 to 100.4 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Sell | U | 0.00 | 220,535 | 0 | 0 | 220.5 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Option Exercise | M | 0.00 | 100,443 | 0 | 18,174 | |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Sell | U | 0.00 | 100,443 | 0 | 0 | 100.4 K to 0 (-100.00 %) |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Buy | M | 0.00 | 100,443 | 0 | 100,443 | 0 to 100.4 K |
Feb 25 2009 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Sell | U | 0.00 | 100,517 | 0 | 0 | 100.5 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 4,873 | 0 | 0 | 4.9 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 32,967 | 0 | 0 | 33 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 146,556 | 0 | 0 | 146.6 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 749,734 | 0 | 0 | 749.7 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 142,545 | 0 | 0 | 142.5 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 265,695 | 0 | 0 | 265.7 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 343,024 | 0 | 0 | 343 K to 0 (-100.00 %) |
Feb 24 2009 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | U | 0.00 | 549,972 | 0 | 0 | 550 K to 0 (-100.00 %) |
Mar 23 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 8,619,330 | 0 | 100 | -8,619,230 to 100 (-100.00 %) |
Mar 23 2009 | IDEV | Endo Pharmaceutica ... | ENDO PHARMACEUTICALS HOLDINGS ... | 10% Owner | Buy | P | 0.00 | 11,306,421 | 0 | 82,162,666 | 70.9 M to 82.2 M (+15.96 %) |
Dec 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 344,000 | |
Dec 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 2.77 | 5,000 | 13,834 | 83,258 | 88.3 K to 83.3 K (-5.67 %) |
Dec 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 88,258 | 83.3 K to 88.3 K (+6.01 %) |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 4.00 | 250,000 | 1,000,000 | 250,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 4.00 | 250,000 | 1,000,000 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 6.00 | 125,000 | 750,000 | 125,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 6.00 | 125,000 | 750,000 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | A | 4.16 | 60,000 | 249,378 | 60,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | D | 4.16 | 60,000 | 249,378 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | A | 6.19 | 550,000 | 3,403,125 | 550,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | D | 6.19 | 550,000 | 3,403,125 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 70,000 | 433,125 | 70,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 70,000 | 433,125 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 360,000 | 1,496,268 | 360,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 360,000 | 1,496,268 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,950,000 | 800,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,950,000 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | A | 3.63 | 5,000 | 18,125 | 5,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | D | 3.63 | 5,000 | 18,125 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | A | 6.19 | 31,000 | 191,890 | 31,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | D | 6.19 | 31,000 | 191,890 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | A | 6.19 | 45,000 | 278,550 | 45,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | D | 6.19 | 45,000 | 278,550 | 0 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | A | 3.56 | 45,000 | 160,200 | 45,000 | |
Dec 08 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | D | 3.56 | 45,000 | 160,200 | 0 | |
Oct 02 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Grant | A | 2.85 | 1,319 | 3,759 | 12,460 | 11.1 K to 12.5 K (+11.84 %) |
Oct 02 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.85 | 2,711 | 7,726 | 83,258 | 80.5 K to 83.3 K (+3.37 %) |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 349,000 | |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 2.86 | 1,000 | 2,860 | 80,547 | 81.5 K to 80.5 K (-1.23 %) |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 2.87 | 1,200 | 3,444 | 81,547 | 82.7 K to 81.5 K (-1.45 %) |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 2.88 | 1,000 | 2,880 | 82,747 | 83.7 K to 82.7 K (-1.19 %) |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 2.89 | 1,800 | 5,202 | 83,747 | 85.5 K to 83.7 K (-2.10 %) |
Sep 30 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 85,547 | 80.5 K to 85.5 K (+6.21 %) |
Sep 29 2008 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Grant | A | 0.00 | 55,918 | 0 | 90,517 | 34.6 K to 90.5 K (+161.62 %) |
Sep 29 2008 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Grant | A | 0.00 | 158,191 | 0 | 467,091 | 308.9 K to 467.1 K (+51.21 %) |
Sep 29 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Grant | A | 0.00 | 55,918 | 0 | 220,535 | 164.6 K to 220.5 K (+33.97 %) |
Sep 29 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 0.00 | 55,918 | 0 | 130,601 | 74.7 K to 130.6 K (+74.87 %) |
Sep 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 0.00 | 55,918 | 0 | 80,547 | 24.6 K to 80.5 K (+227.04 %) |
Aug 11 2008 | IDEV | Endo Pharmaceutica ... | RITTER DALE | Senior Vice Preside ... | Option Exercise | A | 1.67 | 15,000 | 25,050 | 15,000 | |
May 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 354,000 | |
May 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 4.52 | 5,000 | 22,600 | 24,629 | 29.6 K to 24.6 K (-16.88 %) |
May 29 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 29,629 | 24.6 K to 29.6 K (+20.30 %) |
Apr 28 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 359,000 | |
Apr 28 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 4.65 | 5,000 | 23,250 | 24,629 | 29.6 K to 24.6 K (-16.88 %) |
Apr 28 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 29,629 | 24.6 K to 29.6 K (+20.30 %) |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 4.00 | 250,000 | 1,000,000 | 250,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 4.00 | 250,000 | 1,000,000 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 6.00 | 125,000 | 750,000 | 125,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 6.00 | 125,000 | 750,000 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | A | 4.06 | 375,000 | 1,523,438 | 375,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | ROGERS MICHAEL W | Executive Vice Pres ... | Option Exercise | D | 4.06 | 375,000 | 1,523,438 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Option Exercise | A | 6.00 | 45,000 | 270,000 | 45,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | Beerman Noah D | Executive Vice Pres ... | Option Exercise | D | 6.00 | 45,000 | 270,000 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 4.16 | 160,000 | 665,008 | 160,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 4.16 | 160,000 | 665,008 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 6.19 | 500,000 | 3,093,750 | 500,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 6.19 | 500,000 | 3,093,750 | 0 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Apr 15 2008 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Mar 20 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Option Exercise | M | 2.38 | 5,000 | 11,875 | 364,000 | |
Mar 20 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | D | 4.50 | 5,000 | 22,500 | 24,629 | 29.6 K to 24.6 K (-16.88 %) |
Mar 20 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Grant | A | 2.38 | 5,000 | 11,875 | 29,629 | 24.6 K to 29.6 K (+20.30 %) |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | BUTLER MARK S | Executive Vice Pres ... | Sell | S | 4.82 | 19,200 | 92,544 | 24,629 | 43.8 K to 24.6 K (-43.81 %) |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | MORLEY CHERYL P | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | HANSON MICHAEL E | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | FERRARA ANDREW J | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 28 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Option Exercise | M | 4.16 | 5,000 | 20,782 | 0 | |
Jan 28 2008 | IDEV | Endo Pharmaceutica ... | MORVILLE MALCOLM | Director | Buy | M | 4.16 | 5,000 | 20,782 | 27,000 | 22 K to 27 K (+22.73 %) |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 122,725 | 0 | 568,562 | 691.3 K to 568.6 K (-17.75 %) |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 172,788 | 0 | 738,317 | 911.1 K to 738.3 K (-18.96 %) |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 215,885 | 0 | 421,191 | 637.1 K to 421.2 K (-33.89 %) |